382 related articles for article (PubMed ID: 28647906)
1. Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting.
Zimmers TA; Jiang Y; Wang M; Liang TW; Rupert JE; Au ED; Marino FE; Couch ME; Koniaris LG
Basic Res Cardiol; 2017 Jul; 112(4):48. PubMed ID: 28647906
[TBL] [Abstract][Full Text] [Related]
2. Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects?
Harper SC; Brack A; MacDonnell S; Franti M; Olwin BB; Bailey BA; Rudnicki MA; Houser SR
Circ Res; 2016 Apr; 118(7):1143-50; discussion 1150. PubMed ID: 27034276
[TBL] [Abstract][Full Text] [Related]
3. Supraphysiologic Administration of GDF11 Induces Cachexia in Part by Upregulating GDF15.
Jones JE; Cadena SM; Gong C; Wang X; Chen Z; Wang SX; Vickers C; Chen H; Lach-Trifilieff E; Hadcock JR; Glass DJ
Cell Rep; 2018 Feb; 22(6):1522-1530. PubMed ID: 29425507
[TBL] [Abstract][Full Text] [Related]
4. Supraphysiological levels of GDF11 induce striated muscle atrophy.
Hammers DW; Merscham-Banda M; Hsiao JY; Engst S; Hartman JJ; Sweeney HL
EMBO Mol Med; 2017 Apr; 9(4):531-544. PubMed ID: 28270449
[TBL] [Abstract][Full Text] [Related]
5. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
[TBL] [Abstract][Full Text] [Related]
6. The role of GDF11 in aging and skeletal muscle, cardiac and bone homeostasis.
Egerman MA; Glass DJ
Crit Rev Biochem Mol Biol; 2019 Apr; 54(2):174-183. PubMed ID: 31144559
[TBL] [Abstract][Full Text] [Related]
7. GDF11 Decreases Pressure Overload-Induced Hypertrophy, but Can Cause Severe Cachexia and Premature Death.
Harper SC; Johnson J; Borghetti G; Zhao H; Wang T; Wallner M; Kubo H; Feldsott EA; Yang Y; Joo Y; Gou X; Sabri AK; Gupta P; Myzithras M; Khalil A; Franti M; Houser SR
Circ Res; 2018 Nov; 123(11):1220-1231. PubMed ID: 30571461
[TBL] [Abstract][Full Text] [Related]
8. Treatment with rGDF11 does not improve the dystrophic muscle pathology of mdx mice.
Rinaldi F; Zhang Y; Mondragon-Gonzalez R; Harvey J; Perlingeiro RCR
Skelet Muscle; 2016; 6():21. PubMed ID: 27303621
[TBL] [Abstract][Full Text] [Related]
9. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
Morvan F; Rondeau JM; Zou C; Minetti G; Scheufler C; Scharenberg M; Jacobi C; Brebbia P; Ritter V; Toussaint G; Koelbing C; Leber X; Schilb A; Witte F; Lehmann S; Koch E; Geisse S; Glass DJ; Lach-Trifilieff E
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12448-12453. PubMed ID: 29109273
[TBL] [Abstract][Full Text] [Related]
10. Reduced Circulating GDF11 Is Unlikely Responsible for Age-Dependent Changes in Mouse Heart, Muscle, and Brain.
Rodgers BD; Eldridge JA
Endocrinology; 2015 Nov; 156(11):3885-8. PubMed ID: 26372181
[TBL] [Abstract][Full Text] [Related]
11. Exogenous GDF11 attenuates non-canonical TGF-β signaling to protect the heart from acute myocardial ischemia-reperfusion injury.
Su HH; Liao JM; Wang YH; Chen KM; Lin CW; Lee IH; Li YJ; Huang JY; Tsai SK; Yen JC; Huang SS
Basic Res Cardiol; 2019 Mar; 114(3):20. PubMed ID: 30900023
[TBL] [Abstract][Full Text] [Related]
12. GDF11 does not rescue aging-related pathological hypertrophy.
Smith SC; Zhang X; Zhang X; Gross P; Starosta T; Mohsin S; Franti M; Gupta P; Hayes D; Myzithras M; Kahn J; Tanner J; Weldon SM; Khalil A; Guo X; Sabri A; Chen X; MacDonnell S; Houser SR
Circ Res; 2015 Nov; 117(11):926-32. PubMed ID: 26383970
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiological levels of GDF11 activate Smad2/Smad3 signaling and induce muscle atrophy in human iPSC-derived myocytes.
Honda M; Makino T; Zhao X; Matsuto M; Sakurai H; Takahashi Y; Shimizu M; Sato R; Yamauchi Y
Am J Physiol Cell Physiol; 2022 Nov; 323(5):C1402-C1409. PubMed ID: 36094432
[TBL] [Abstract][Full Text] [Related]
14. DA-Raf and the MEK inhibitor trametinib reverse skeletal myocyte differentiation inhibition or muscle atrophy caused by myostatin and GDF11 through the non-Smad Ras-ERK pathway.
Masuzawa R; Takahashi K; Takano K; Nishino I; Sakai T; Endo T
J Biochem; 2022 Jan; 171(1):109-122. PubMed ID: 34676394
[TBL] [Abstract][Full Text] [Related]
15. Neonatal Systemic AAV-Mediated Gene Delivery of GDF11 Inhibits Skeletal Muscle Growth.
Jin Q; Qiao C; Li J; Li J; Xiao X
Mol Ther; 2018 Apr; 26(4):1109-1117. PubMed ID: 29503194
[TBL] [Abstract][Full Text] [Related]
16. Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration.
Rochette L; Zeller M; Cottin Y; Vergely C
Pharmacol Ther; 2015 Dec; 156():26-33. PubMed ID: 26523637
[TBL] [Abstract][Full Text] [Related]
17. GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration.
Egerman MA; Cadena SM; Gilbert JA; Meyer A; Nelson HN; Swalley SE; Mallozzi C; Jacobi C; Jennings LL; Clay I; Laurent G; Ma S; Brachat S; Lach-Trifilieff E; Shavlakadze T; Trendelenburg AU; Brack AS; Glass DJ
Cell Metab; 2015 Jul; 22(1):164-74. PubMed ID: 26001423
[TBL] [Abstract][Full Text] [Related]
18. The Growth Differentiation Factor 11 (GDF11) and Myostatin (MSTN) in tissue specific aging.
Fan X; Gaur U; Sun L; Yang D; Yang M
Mech Ageing Dev; 2017 Jun; 164():108-112. PubMed ID: 28472635
[TBL] [Abstract][Full Text] [Related]
19. GDF11 Inhibits Bone Formation by Activating Smad2/3 in Bone Marrow Mesenchymal Stem Cells.
Lu Q; Tu ML; Li CJ; Zhang L; Jiang TJ; Liu T; Luo XH
Calcif Tissue Int; 2016 Nov; 99(5):500-509. PubMed ID: 27395058
[TBL] [Abstract][Full Text] [Related]
20. Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.
Walker RG; Poggioli T; Katsimpardi L; Buchanan SM; Oh J; Wattrus S; Heidecker B; Fong YW; Rubin LL; Ganz P; Thompson TB; Wagers AJ; Lee RT
Circ Res; 2016 Apr; 118(7):1125-41; discussion 1142. PubMed ID: 27034275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
